Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Jonas Insider Profile
4 Followers
Jeffrey Jonas, President & CEO, Director at SAGE Therapeutics, holds 54.53K shares in SAGE Therapeutics (Ticker: SAGE), holds ― shares in Karuna Therapeutics (Ticker: KRTX), holds ― shares in Generation Bio (Ticker: GBIO). Most recently, Jeffrey Jonas Bought ― shares of SAGE Therapeutics on Dec 10, 2019 for an estimated value of 481.50K.
Jeffrey Jonas SAGE Therapeutics (SAGE)President & CEO, Director
SAGE Therapeutics (SAGE)
President & CEO, Director
Ranked #42,965 out of 78,624 Corporate Insiders
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-2.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Jonas holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Jonas
Jeffrey Jonas's Trading History
SAGE Therapeutics
Dec 10, 2019
President & CEO, Director
Informative Buy
481.50K
$4.12M
Karuna Therapeutics
―
Director
―
―
Generation Bio
―
Director
―
―
Ionis Pharmaceuticals
―
EVP
―
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Jonas's performance on stock
You May Also Like
Jeffrey Jonas insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Jonas?
The percentage of profitable transactions made by Jeffrey Jonas is 43%.
What is the average return per transaction made by Jeffrey Jonas?
The average return per transaction made by Jeffrey Jonas is -2.00%.
What stocks does Jeffrey Jonas hold?
Jeffrey Jonas holds: SAGE, KRTX, GBIO, IONS stocks.
What was Jeffrey Jonas’s latest transaction?
Jeffrey Jonas latest transaction was an Informative Buy of $481.50K.
What was Jeffrey Jonas's most profitable transaction?
Jeffrey Jonas’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
What is Jeffrey Jonas's role in SAGE Therapeutics?
Jeffrey Jonas's role in SAGE Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.